GM2 Gangliosidosis
Showing 26 - 50 of 7,724
Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)
Recruiting
- Recurrent Osteosarcoma
- humanized anti-GD2 antibody
- GM-CSF
-
Los Angeles, California
- +2 more
Dec 22, 2022
Melanoma Trial in Beijing (OH2 injection, HX008 injection)
Recruiting
- Melanoma
- OH2 injection
- HX008 injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 28, 2023
Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)
Completed
- Neuroblastoma
- anti-GD2 murine IgG3 monoclonal antibody 3F8
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Apr 21, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)
Terminated
- Neuroblastoma Recurrent
- Naxitamab and GM-CSF in combination with irinotecan and temozolomide
-
Hong Kong, Hong Kong
- +2 more
Nov 8, 2022
Immune Checkpoint Inhibitors Nephrotoxicity
Recruiting
- Kidney Injury
- Antineoplastics Toxicity
- Early kidney damage biomarkers
- Predisposition to kidney injury biomarkers
-
Salamanca, Spain
- +1 more
Jul 26, 2022
Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,
Active, not recruiting
- Bilateral Breast Carcinoma
- +11 more
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +11 more
Jan 12, 2023
Advanced Refractory Solid Tumors Trial in China (Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF)
Recruiting
- Advanced Refractory Solid Tumors
- Hypofractionated radiotherapy
- +3 more
-
Beijing, China
- +15 more
Aug 8, 2022
Episiotomy Wound Trial (10 ml of lidocaine 2%, lidocaine prilocaine cream 15gm)
Not yet recruiting
- Episiotomy Wound
- 10 ml of lidocaine 2%
- lidocaine prilocaine cream 15gm
- (no location specified)
Jun 5, 2023
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Radiation Proctopathy Trial in Manchester (Purastat Arm, Standard Care Arm)
Recruiting
- Radiation Proctopathy
- Purastat Arm
- Standard Care Arm
-
Manchester, United KingdomManchester University NHS Foundation Trust
Jan 30, 2023
Orthognathic Surgical Site Infection Trial (Cefazolin 2 GM Injection, Cefazolin Injection)
Not yet recruiting
- Orthognathic Surgical Site Infection
- Cefazolin 2 GM Injection
- Cefazolin Injection
- (no location specified)
May 14, 2023
Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)
Recruiting
- Metastatic Cancer
- Keytruda Injectable Product
- +4 more
-
Rochester, MichiganAscension Providence Rochester Hospital
Jun 15, 2022
Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester
Active, not recruiting
- Childhood Astrocytoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
Solid Tumor, Melanoma Trial in Beijing (OH2 injection, Keytruda)
Recruiting
- Solid Tumor
- Melanoma
- OH2 injection
- Keytruda
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Apr 1, 2022
Breast Cancer Trial in United States (Placebo, GLSI-100)
Recruiting
- Breast Cancer
- Placebo
- GLSI-100
-
Birmingham, Alabama
- +21 more
Jan 30, 2023
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body
Recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Pancreatic Ductal Adenocarcinoma
- Stereotactic Body Radiation (SBRT)
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 28, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +3 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Osteomyelitis Tibia, Tibial Fractures, Open tíbia Fracture Trial in United States (Antibiotic coated intramedullary Nail,
Not yet recruiting
- Osteomyelitis Tibia
- +2 more
- Antibiotic coated intramedullary Nail
- Standard Intramedullary Nail
-
Temple Terrace, Florida
- +8 more
Jun 13, 2022
Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,
Recruiting
- Breast Ductal Carcinoma In Situ
- Granulocyte-Macrophage Colony-Stimulating Factor
- +2 more
-
Jacksonville, Florida
- +1 more
Dec 10, 2021
Advanced Adenocarcinoma, Advanced Malignant Solid Tumor, Metastatic Adenocarcinoma Trial in Sacramento (Antineoplastic Vaccine,
Recruiting
- Advanced Adenocarcinoma
- +5 more
- Antineoplastic Vaccine
- Sargramostim
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 29, 2021
Amyotrophic Lateral Sclerosis Trial in Boston, New York (GM604, Placebo comparator)
Completed
- Amyotrophic Lateral Sclerosis
- GM604
- Placebo comparator
-
Boston, Massachusetts
- +1 more
Apr 23, 2021